Free Trial Free TrialFree Trial

More results...

Filter by Content types
Regulatory databases
Regulatory reports
Market reports
News analysis
Filter by Geography
Africa
Asia
Australasia
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • Brazil Supreme Court postpones drug possession decriminalisation ruling…
  • Europe MEP raises concerns over HHC…
  • United States Bipartisan bill would distinguish between ‘industrial’ and other hemp…
  • Nevada - United States Senate backs rise in limits on cannabis possession…
  • Oklahoma - United States Medical Marijuana Authority given laboratory rights…
  • California - United States Assembly approves catering and events on cannabis premises…
  • California - United States Assembly seeks to make hemp licence rules clearer…
  • Colombia Senate reschedules debate on recreational cannabis bill…
  • Czech Republic Health minister remains circumspect on cannabis legalisation…
  • Thailand Cannabis network urges against reinstating narcotics status…
  • United States Hemp Roundtable criticise FDA over CBD regulation…
  • Minnesota - United States Recreational cannabis to be legal from 1st August…
View all
News analysis

A ‘milestone’ for psychedelics as clinical trial begins in US with FDA’s blessing

Written by || 18th July 2022 || News analysis | Psychedelics | GeographiesNorth America United States

As the first federally approved psychedelics clinical trial begins in the US, there is broad but not total agreement among official bodies over legalising research into hallucinogenic substances.

The first Phase 1 study into psilocin and psilocybin to be approved by the US Food and Drug Administration (FDA) will examine the physiological and psychological effects of the mushroom-derived compounds when delivered orally and sublingually to healthy adults.

Read more
I'm already a subscriber

Login

Author default picture

Freddie Dawson

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Thanks for getting in touch with us

Please leave your enquiry and we will get back to you within 24 hours









    CannIntelligence.com provides independent, in-depth regulatory and market data and intelligence for the global cannabis and cannabinoid sector.